• Image of Micronase medication Image of Micronase medication
    • GLYBURIDE

    • QTY 90
    • 5 MG
    • Tablet
    • Near  77381

GLYBURIDE (GLYE byoor ide) treats type 2 diabetes. It works by increasing insulin levels in your body, which decreases your blood sugar (glucose). It also helps your body use insulin more effectively. It belongs to a group of medications called sulfonylureas. Changes to diet and exercise are often combined with this medication.


What does GLYBURIDE look like?

View images of GLYBURIDE and identify pills by imprint, color or shape. If you need to save money on your GLYBURIDE, compare our prices. Our prescription savings may even be lower than your insurance copay!

Note: Multiple images may be displayed for medicines available in different strengths, sold under different brand names, or manufactured by different pharmaceutical companies.

Glipizide 5mg Tablet
Glipizide 5mg Tablet

Strength: 5 MG

Pill Imprint: 315

Color: white

Shape: round

Glipizide 5mg Tablet
Glipizide 5mg Tablet

Strength: 5 MG

Pill Imprint: ANI

Color: white

Shape: round

Glipizide 5mg Tablet
Glipizide 5mg Tablet

Strength: 5 MG

Pill Imprint: APO

Color: white

Shape: round

Glipizide 5mg Tablet
Glipizide 5mg Tablet

Strength: 5 MG

Pill Imprint: GG 771

Color: white

Shape: round

Glipizide 5mg Tablet
Glipizide 5mg Tablet

Strength: 5 MG

Pill Imprint: GLP 5

Color: white

Shape: round

Glipizide 5mg Tablet
Glipizide 5mg Tablet

Strength: 5 MG

Pill Imprint: MYLAN G1

Color: white

Shape: round

Glipizide 5mg Tablet
Glipizide 5mg Tablet

Strength: 5 MG

Pill Imprint: WATSON 460

Color: white

Shape: round

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment. Drug information is sourced from GSDD (Gold Standard Drug Database ) provided by Elsevier.